MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases GlobeNewswire Sep 16, 2024 6:00am
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference GlobeNewswire Sep 5, 2024 8:05pm
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance GlobeNewswire Aug 6, 2024 8:05pm
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024 GlobeNewswire Jul 9, 2024 8:05pm